TARCEVA (Genentech, Inc.)
Welcome to the PulseAid listing for the TARCEVA drug offered from Genentech, Inc.. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genentech, Inc. |
| NON-PROPRIETARY NAME: | erlotinib hydrochloride |
| SUBSTANCE NAME: | ERLOTINIB HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-04-30 |
| END MARKETING DATE: | 0000-00-00 |
TARCEVA HUMAN PRESCRIPTION DRUG Details:
| Item Description | TARCEVA from Genentech, Inc. |
| LABELER NAME: | Genentech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2005-04-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50242-062_6631b633-d740-45eb-a544-f802a2848db2 |
| PRODUCT NDC: | 50242-062 |
| APPLICATION NUMBER: | NDA021743 |
Other ERLOTINIB HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
